{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:03:24Z","timestamp":1794557004480,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.bone.2009.08.004","type":"journal-article","created":{"date-parts":[[2009,8,12]],"date-time":"2009-08-12T10:04:03Z","timestamp":1250071443000},"page":"1059-1064","source":"Crossref","is-referenced-by-count":103,"title":["Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8\u00a0years"],"prefix":"10.1016","volume":"45","author":[{"given":"J.Y.","family":"Reginster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sawicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Roces-Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fardellone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Devogelaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2009.08.004_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbspin.2006.05.011","article-title":"How long should patients take medications for postmenopausal osteoporosis?","volume":"74","author":"Briot","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.bone.2009.08.004_bib2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00223-004-0286-7","article-title":"Seven years of treatment with risedronate in women with postmenopausal osteoporosis","volume":"75","author":"Mellstrom","year":"2004","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2009.08.004_bib3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2009.08.004_bib4","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1359\/JBMR.050509","article-title":"Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study","volume":"20","author":"Siris","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.08.004_bib5","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment The Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2009.08.004_bib6","first-page":"S301","article-title":"SU375: strontium promotes human osteoblast replication and decreases their osteoclastogenic abilities in primary human osteoblasts","volume":"21","author":"Brennan","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.08.004_bib7","first-page":"S72","article-title":"P132-T: strontium ranelate effects in human osteoblasts support its uncoupling effect on bone formation and bone resorption","volume":"80","author":"Brennan","year":"2007","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2009.08.004_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(02)02040-X","article-title":"In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differenciation","volume":"450","author":"Baron","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bone.2009.08.004_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s002230010055","article-title":"Mechanisms of action and therapeutic potential of strontium in bone","volume":"69","author":"Marie","year":"2001","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2009.08.004_bib10","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.bone.2007.02.003","article-title":"Strontium ranelate: new insights into its dual mode of action","volume":"40","author":"Marie","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.08.004_bib11","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1359\/jbmr.040906","article-title":"Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats","volume":"19","author":"Ammann","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.08.004_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1359\/jbmr.071012","article-title":"Histomorphometric and mu-CT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate","volume":"23","author":"Arlot","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.08.004_bib13","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2009.08.004_bib14","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study","volume":"90","author":"Reginster","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2009.08.004_bib15","first-page":"S26","article-title":"OC49: strontium ranelate demonstrates efficacy against hip fracture over 3 and 5 years in postmenopausal women at high risk of hip fracture","volume":"19","author":"Reginster","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2009.08.004_bib16","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.23461","article-title":"Effects of long-term strontium ranelate treatment on the risk of non-vertebral and vertebral fractures in postmenopausal osteoporosis: results of a 5-year, randomized, placebo-controlled trial","volume":"58","author":"Reginster","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"Suppl. 3","key":"10.1016\/j.bone.2009.08.004_bib17","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1007\/s00198-002-1341-8","article-title":"Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis","volume":"14","author":"Meunier","year":"2003","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2009.08.004_bib18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1359\/jbmr.060101","article-title":"Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors","volume":"21","author":"Roux","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.08.004_bib19","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.08.004_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1385\/JCD:2:1:37","article-title":"The use of different dual X-ray absorptiometry brands in a multicenter clinical trial. Consequences and limits","volume":"2","author":"Slosman","year":"1999","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bone.2009.08.004_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00198-005-0027-4","article-title":"The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA)","volume":"17","author":"Siris","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2009.08.004_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1359\/jbmr.070814","article-title":"Risk factors for vertebral and nonvertebral fracture over 10 years: a population-based study in women","volume":"23","author":"Finigan","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.08.004_bib23","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","article-title":"Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2009.08.004_bib24","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1001\/jama.298.23.2761","article-title":"Long-term risk of incident vertebral fractures","volume":"298","author":"Cauley","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2009.08.004_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2009.08.004_bib26","doi-asserted-by":"crossref","unstructured":"Boivin et al. In osteoporotic women treated with strontium ranelate, stontium is located in bone formed during treatment with a maintained degree of mineralisation. Ostoporosis international. 2009 Jul 14.","DOI":"10.1007\/s00198-009-1005-z"},{"key":"10.1016\/j.bone.2009.08.004_bib27","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1210\/jc.2006-2758","article-title":"Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate","volume":"92","author":"Bruyere","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2009.08.004_bib28","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1001\/jama.296.24.2968","article-title":"Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing","volume":"296","author":"Colon-Emeric","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2009.08.004_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2009.08.004_bib30","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2009.08.004_bib31","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0140-6736(06)69394-X","article-title":"Compliance with osteoporosis therapy is the weakest link","volume":"368","author":"Compston","year":"2006","journal-title":"Lancet"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632820901816X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S875632820901816X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T23:49:03Z","timestamp":1558482543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S875632820901816X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S875632820901816X"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2009.08.004","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}